Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiebke Stark

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Neurology|March 21, 2009
Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and AdolescenceWiebke Stark, Peter Huppke, Jutta Gärtner
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosisBrenda Huppke, Marie-Christine Reinert, Wiebke Stark, et al.
Archives of Neurology|December 10, 2008
Natalizumab use in pediatric multiple sclerosisPeter Huppke, Wiebke Stark, Claudia Zürcher, et al.
Plos One|March 23, 2018
Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patientsEva Wuerfel, Almuth Weddige, York Hagmayer, et al.
Neurology|September 25, 2023
Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple SclerosisBrenda Huppke, Marie-Christine Reinert, Hannah Hummel-Abmeier, et al.
JAMA Neurology|July 16, 2019
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in ChildrenBrenda Huppke, David Ellenberger, Hannah Hummel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severityPeter Huppke, Hanna Hummel, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
American Journal of Medical Genetics. Part A|January 28, 2017
Continuing role for classical cytogenetics: Case report of a boy with ring syndrome caused by complete ring chromosome 4 and review of literatureAnna Lena Burgemeister, Eva Daumiller, Ilona Dietze-Armana, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 15, 2020
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisMarie-Christine Reinert, Pascal Benkert, Jens Wuerfel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Neurology|March 21, 2009
Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and AdolescenceWiebke Stark, Peter Huppke, Jutta Gärtner
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosisBrenda Huppke, Marie-Christine Reinert, Wiebke Stark, et al.
Archives of Neurology|December 10, 2008
Natalizumab use in pediatric multiple sclerosisPeter Huppke, Wiebke Stark, Claudia Zürcher, et al.
Plos One|March 23, 2018
Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patientsEva Wuerfel, Almuth Weddige, York Hagmayer, et al.
Neurology|September 25, 2023
Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple SclerosisBrenda Huppke, Marie-Christine Reinert, Hannah Hummel-Abmeier, et al.
JAMA Neurology|July 16, 2019
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in ChildrenBrenda Huppke, David Ellenberger, Hannah Hummel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severityPeter Huppke, Hanna Hummel, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
American Journal of Medical Genetics. Part A|January 28, 2017
Continuing role for classical cytogenetics: Case report of a boy with ring syndrome caused by complete ring chromosome 4 and review of literatureAnna Lena Burgemeister, Eva Daumiller, Ilona Dietze-Armana, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 15, 2020
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisMarie-Christine Reinert, Pascal Benkert, Jens Wuerfel, et al.
Pageof 1